Osaic Holdings
ARKG icon

Osaic Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History

Osaic Holdings’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.04M Buy
143,691
+12,835
+10% +$409K 0.01% 1383
2026
Q1 		$3.46M Sell
130,856
-10,836
-8% -$317K 0.01% 1617
2025
Q4 		$4.1M Buy
141,692
+44,098
+45% +$1.32M 0.01% 1509
2025
Q3 		$2.49M Sell
97,594
-11,759
-11% -$297K ﹤0.01% 1987
2025
Q2 		$2.66M Buy
109,353
+15,072
+16% +$330K ﹤0.01% 1681
2025
Q1 		$1.96M Buy
94,281
+1,181
+1% +$29.7K ﹤0.01% 1688
2024
Q4 		$2.19M Sell
93,100
-3,001
-3% -$73.9K ﹤0.01% 1589
2024
Q3 		$2.46M Sell
96,101
-8,451
-8% -$215K 0.01% 1533
2024
Q2 		$2.45M Sell
104,552
-76,920
-42% -$1.94M 0.01% 1475
2024
Q1 		$5.21M Sell
181,472
-14,437
-7% -$434K 0.01% 1006
2023
Q4 		$6.43M Sell
195,909
-81,879
-29% -$2.23M 0.01% 1037
2023
Q3 		$7.72M Buy
277,788
+6,350
+2% +$208K 0.01% 1008
2023
Q2 		$9.26M Sell
271,438
-11,305
-4% -$355K 0.02% 806
2023
Q1 		$8.5M Buy
282,743
+13,979
+5% +$433K 0.02% 838
2022
Q4 		$7.59M Sell
268,764
-17,769
-6% -$564K 0.02% 861
2022
Q3 		$9.42M Sell
286,533
-9,736
-3% -$357K 0.02% 690
2022
Q2 		$9.36M Sell
296,269
-28,567
-9% -$999K 0.02% 700
2022
Q1 		$13.7M Sell
324,836
-100,667
-24% -$4.8M 0.03% 595
2021
Q4 		$26.1M Sell
425,503
-94,421
-18% -$6.53M 0.05% 347
2021
Q3 		$38.9M Sell
519,924
-47,025
-8% -$3.95M 0.08% 239
2021
Q2 		$52.5M Sell
566,949
-8,370
-1% -$712K 0.11% 186
2021
Q1 		$51.1M Buy
575,319
+54,423
+10% +$5.4M 0.12% 180
2020
Q4 		$48.6M Buy
520,896
+283,296
+119% +$22.6M 0.13% 164
2020
Q3 		$14.7M Buy
237,600
+90,042
+61% +$5.28M 0.04% 358
2020
Q2 		$7.42M Buy
147,558
+36,722
+33% +$1.58M 0.02% 546
2020
Q1 		$3.32M Buy
+110,836
New +$3.7M 0.01% 786

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Osaic Holdings's ARKG Position: Q2 2026 in Review

Osaic Holdings increased its ARK Genomic Revolution ETF (ARKG) stake by 9.8% in Q2 2026, buying an estimated $409K and bringing the position to 143,691 shares worth $6.04M. The position accounts for 0.01% of the portfolio, ranked #1383.

Osaic Holdings first reported a position in ARKG in Q1 2020 and has held it in 26 quarters since. The position peaked at $52.5M in Q2 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Osaic Holdings held 143,691 shares of ARK Genomic Revolution ETF worth $6.04M as of Q2 2026.
  • Osaic Holdings bought 12,835 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $409K.
  • ARK Genomic Revolution ETF made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1383 holding.
  • Osaic Holdings first reported a position in ARK Genomic Revolution ETF in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's ARK Genomic Revolution ETF position peaked at $52.5M in Q2 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.